CNC Stock Centene Corporation
US · NYSELast in our picks 2026-10-25 — not in the current list; analysis below is from that screen
Medicaid execution and cost discipline could drive a meaningful re-rating from depressed levels.
Future value: $71.78 (+2.29%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Turnaround potential and low valuation attract institutional recovery positioning.
- ▸Above 50-day MA (+6.63%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (94.3% of range) — strength
Is CNC a buy right now?
Trend: CNC is trading above the 50-day average (+3.64%), RSI 60 — neutral momentum, with a 3-month return of +6.74%.
Valuation & quality: Centene Corporation trades on forward P/E 12.8, PEG 0.85, price-to-book 1.49; fundamentals show net margin -2.8%, return on equity -20.4%, revenue growth 4.6% year on year.
Analyst consensus: 18 analysts have a mean 12-month price target of $71.78 (+5.2% vs the last close; range $56.00 – $85.00), consensus rating “buy”.
Our screen: STRONG BUY (score 4) — Medicaid execution and cost discipline could drive a meaningful re-rating from depressed levels.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -27.00% | +64.00% | +11.00% | +7.70% | -3.10% | +3.40% | -3.50% | +9.80% |
Fundamentals
Analyst price target
Technical signals
About Centene Corporation
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Sector: Healthcare · Industry: Healthcare Plans · United States · 61,100 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.